These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9797421)

  • 1. Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results.
    García-Rodríguez JA
    Chemotherapy; 1998 Sep; 44 Suppl 1():28-30. PubMed ID: 9797421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
    Jacobs MR; Bajaksouzian S
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):105-12. PubMed ID: 9294699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of amoxicillin and clavulanic acid and quinolones as first choice antibiotics in uncomplicated urinary tract infections in Spain should be reviewed.
    Llor C; Aspiroz C; Cano A; Barranco M
    Aten Primaria; 2012 Jul; 44(7):443-4. PubMed ID: 22265580
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of cefixime versus amoxicillin-clavulanic acid combination in the oral treatment of urinary tract infections in children].
    François P; Croizé J; Bost C; Wollschlager K
    Arch Pediatr; 1995 Feb; 2(2):136-42. PubMed ID: 7735445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
    Matsumoto Y
    Chemotherapy; 1998 Sep; 44 Suppl 1():6-9. PubMed ID: 9797416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
    Hamilton-Miller JM; Brumfitt W
    Drugs Exp Clin Res; 1991; 17(10-11):517-9. PubMed ID: 1841042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical role of cefixime in community-acquired infections.
    Chemotherapy; 1998 Sep; 44 Suppl 1():35-8. PubMed ID: 9797423
    [No Abstract]   [Full Text] [Related]  

  • 9. Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae.
    Jones RN; Johnson DM
    Diagn Microbiol Infect Dis; 1998 Jun; 31(2):373-6. PubMed ID: 9635912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, multicenter, comparative study of the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients.
    Iravani A; Richard GA; Johnson D; Bryant A
    Am J Med; 1988 Sep; 85(3A):17-23. PubMed ID: 3048090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of the clinical features of cefixime.
    Adam D
    Chemotherapy; 1998 Sep; 44 Suppl 1():1-5. PubMed ID: 9797415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis].
    Moreno-Martínez A; Mensa J; Martínez JA; Marco F; Vila J; Almela M; García San Miguel J; Soriano E
    Med Clin (Barc); 1998 Oct; 111(14):521-4. PubMed ID: 9859076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cefixime and co-trimoxazole in acute uncomplicated urinary tract infection. A double-blind general practice study.
    Levenstein J; Summerfield PJ; Fourie S; Brink G; Michaelides B; Murray E; Naidoo N
    S Afr Med J; 1986 Oct; 70(8):455-60. PubMed ID: 3535127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An antibiotic policy to prevent emergence of resistant bacilli.
    de Man P; Verhoeven BA; Verbrugh HA; Vos MC; van den Anker JN
    Lancet; 2000 Mar; 355(9208):973-8. PubMed ID: 10768436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefixime in the treatment of respiratory and urinary tract infections.
    Ludwig E
    Chemotherapy; 1998 Sep; 44 Suppl 1():31-4. PubMed ID: 9797422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The etiology of urinary tract infections and antimicrobial susceptibility: study based on children hospitalized in 2012].
    Jackowska T; Chwiećko J; Hartmann P
    Dev Period Med; 2014; 18(4):470-6. PubMed ID: 25874786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
    Amir J; Harel L; Eidlitz-Markus T; Varsano I
    Clin Pediatr (Phila); 1996 Dec; 35(12):629-33. PubMed ID: 8970755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cefixime in the treatment of upper respiratory tract infections and otitis media.
    de Lalla F
    Chemotherapy; 1998 Sep; 44 Suppl 1():19-23. PubMed ID: 9797419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of cefixime versus ceftizoxime against Salmonella typhi.
    Rastegar Lari A; Validi N; Ghaffarzadeh K; Shamshiri AR
    Pathol Biol (Paris); 1997 May; 45(5):415-9. PubMed ID: 9296095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.